Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Response to "A critique for the new Canadian FASD diagnostic Guidelines".

Cook JL, Green CR, Lilley C, Psych R, Anderson S, Baldwin ME, Chudley AE, Conry J, LeBlanc N, Loock CA, Mallon B, McFarlane A, Temple V, Psych C.

J Can Acad Child Adolesc Psychiatry. 2018 Apr;27(2):83-87. Epub 2018 Apr 1. No abstract available.

2.

Effect of sedation on quantitative electroencephalography after cardiac arrest.

Drohan CM, Cardi AI, Rittenberger JC, Popescu A, Callaway CW, Baldwin ME, Elmer J.

Resuscitation. 2018 Mar;124:132-137. doi: 10.1016/j.resuscitation.2017.11.068. Epub 2017 Dec 2.

3.

Features of Simultaneous Scalp and Intracranial EEG That Predict Localization of Ictal Onset Zone.

Abramovici S, Antony A, Baldwin ME, Urban A, Ghearing G, Pan J, Sun T, Krafty RT, Richardson RM, Bagic A.

Clin EEG Neurosci. 2018 May;49(3):206-212. doi: 10.1177/1550059417738688. Epub 2017 Oct 25.

PMID:
29067832
4.

Misleading EEG Lateralization Associated With Midline Shift.

Ghearing GR, Abramovici S, Popescu A, Baldwin ME.

J Clin Neurophysiol. 2017 Nov;34(6):542-545. doi: 10.1097/WNP.0000000000000385.

PMID:
28682826
5.

Continuous EEG monitoring enhances multimodal outcome prediction in hypoxic-ischemic brain injury.

Amorim E, Rittenberger JC, Zheng JJ, Westover MB, Baldwin ME, Callaway CW, Popescu A; Post Cardiac Arrest Service.

Resuscitation. 2016 Dec;109:121-126. doi: 10.1016/j.resuscitation.2016.08.012. Epub 2016 Aug 21.

6.

Group-Based Trajectory Modeling of Suppression Ratio After Cardiac Arrest.

Elmer J, Gianakas JJ, Rittenberger JC, Baldwin ME, Faro J, Plummer C, Shutter LA, Wassel CL, Callaway CW, Fabio A; Pittsburgh Post-Cardiac Arrest Service.

Neurocrit Care. 2016 Dec;25(3):415-423.

7.

Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan.

Cook JL, Green CR, Lilley CM, Anderson SM, Baldwin ME, Chudley AE, Conry JL, LeBlanc N, Loock CA, Lutke J, Mallon BF, McFarlane AA, Temple VK, Rosales T; Canada Fetal Alcohol Spectrum Disorder Research Network.

CMAJ. 2016 Feb 16;188(3):191-197. doi: 10.1503/cmaj.141593. Epub 2015 Dec 14. Review. No abstract available.

8.

The care of the baby's eyes in the perambulator.

Baldwin ME.

JAMA. 2015 Apr 7;313(13):1376. doi: 10.1001/jama.2014.11674. No abstract available.

PMID:
25849194
9.

Malignant EEG patterns in cardiac arrest patients treated with targeted temperature management who survive to hospital discharge.

Amorim E, Rittenberger JC, Baldwin ME, Callaway CW, Popescu A; Post Cardiac Arrest Service.

Resuscitation. 2015 May;90:127-32. doi: 10.1016/j.resuscitation.2015.03.005. Epub 2015 Mar 14.

10.

Differential expression of VEGF ligands and receptors in prostate cancer.

Woollard DJ, Opeskin K, Coso S, Wu D, Baldwin ME, Williams ED.

Prostate. 2013 May;73(6):563-72. doi: 10.1002/pros.22596. Epub 2012 Oct 4.

PMID:
23038639
11.

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, Rupasinghe TW, Tull DL, Baldwin ME, Sloan EK, Fox SB, Achen MG, Stacker SA.

Cancer Cell. 2012 Feb 14;21(2):181-95. doi: 10.1016/j.ccr.2011.12.026.

12.

Visual-evoked potentials for intraoperative neurophysiology monitoring: another flash in the pan?

Cohen BA, Baldwin ME.

J Clin Neurophysiol. 2011 Dec;28(6):599-601. doi: 10.1097/WNP.0b013e31823da5c1. No abstract available.

PMID:
22146354
13.

Manganese cumulative exposure and symptoms: a follow-up study of alloy workers.

Bouchard M, Mergler D, Baldwin ME, Panisset M.

Neurotoxicology. 2008 Jul;29(4):577-83. doi: 10.1016/j.neuro.2008.04.013. Epub 2008 May 2.

PMID:
18562007
14.

Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.

Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, Stacker SA, Achen MG, Alitalo K.

Mol Cell Biol. 2008 Aug;28(15):4843-50. doi: 10.1128/MCB.02214-07. Epub 2008 Jun 2.

15.

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, Fuh G, Gerber HP, Ferrara N.

Nat Biotechnol. 2007 Aug;25(8):911-20. Epub 2007 Jul 29.

PMID:
17664940
16.

Molecular pathways for lymphangiogenesis and their role in human disease.

Stacker SA, Farnsworth RH, Karnezis T, Shayan R, Smith DP, Paavonen K, Davydova N, Caesar C, Inder R, Baldwin ME, McColl BK, Roufail S, Williams RA, Hughes RA, Alitalo K, Achen MG.

Novartis Found Symp. 2007;281:38-43; discussion 44-53, 208-9. Review.

PMID:
17534064
17.

Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.

Thaxton C, Lopera J, Bott M, Baldwin ME, Kalidas P, Fernandez-Valle C.

Mol Cell Neurosci. 2007 Feb;34(2):231-42. Epub 2006 Dec 18.

PMID:
17175165
18.

Corneal avascularity is due to soluble VEGF receptor-1.

Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J.

Nature. 2006 Oct 26;443(7114):993-7. Epub 2006 Oct 18.

19.

Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.

Malik AK, Baldwin ME, Peale F, Fuh G, Liang WC, Lowman H, Meng G, Ferrara N, Gerber HP.

Blood. 2006 Jan 15;107(2):550-7. Epub 2005 Sep 27.

PMID:
16189273
20.

Racial differences in demographics, acute complications, and outcomes in patients with subarachnoid hemorrhage: a large patient series.

Rosen D, Novakovic R, Goldenberg FD, Huo D, Baldwin ME, Frank JI, Rosengart AJ, Macdonald RL.

J Neurosurg. 2005 Jul;103(1):18-24.

PMID:
16121968
21.

Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG.

Mol Cell Biol. 2005 Mar;25(6):2441-9.

22.

Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome.

Baldwin ME, Macdonald RL, Huo D, Novakovic RL, Goldenberg FD, Frank JI, Rosengart AJ.

Stroke. 2004 Nov;35(11):2506-11. Epub 2004 Oct 7. Erratum in: Stroke. 2005 Jan;36(1):175. Novakovia, Roberta L [corrected to Novakovic, Roberta L].

PMID:
15472099
23.

Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.

Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL, Williams ED.

Clin Cancer Res. 2004 Aug 1;10(15):5137-44.

24.

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.

McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA, Achen MG.

J Exp Med. 2003 Sep 15;198(6):863-8. Epub 2003 Sep 8. Erratum in: J Exp Med. 2003 Oct 6;198(7):following 1126.

25.

Regenerating lizard tails: a new model for investigating lymphangiogenesis.

Daniels CB, Lewis BC, Tsopelas C, Munns SL, Orgeig S, Baldwin ME, Stacker SA, Achen MG, Chatterton BE, Cooter RD.

FASEB J. 2003 Mar;17(3):479-81. Epub 2003 Jan 2.

PMID:
12514111
26.

Molecular control of lymphangiogenesis.

Baldwin ME, Stacker SA, Achen MG.

Bioessays. 2002 Nov;24(11):1030-40. Review.

PMID:
12386934
27.

Lymphangiogenesis and cancer metastasis.

Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K.

Nat Rev Cancer. 2002 Aug;2(8):573-83. Review.

PMID:
12154350
28.

The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer.

Achen MG, Williams RA, Baldwin ME, Lai P, Roufail S, Alitalo K, Stacker SA.

Growth Factors. 2002 Jun;20(2):99-107.

PMID:
12148568
29.

The role of tumor lymphangiogenesis in metastatic spread.

Stacker SA, Baldwin ME, Achen MG.

FASEB J. 2002 Jul;16(9):922-34. Review.

PMID:
12087053
30.

Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis.

Baldwin ME, Roufail S, Halford MM, Alitalo K, Stacker SA, Achen MG.

J Biol Chem. 2001 Nov 23;276(47):44307-14. Epub 2001 Sep 26.

31.

The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.

Baldwin ME, Catimel B, Nice EC, Roufail S, Hall NE, Stenvers KL, Karkkainen MJ, Alitalo K, Stacker SA, Achen MG.

J Biol Chem. 2001 Jun 1;276(22):19166-71. Epub 2001 Feb 20.

32.

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG.

Nat Med. 2001 Feb;7(2):186-91.

PMID:
11175849
33.

Features of syndrome X develop in transgenic rats expressing a non-insulin responsive phosphoenolpyruvate carboxykinase gene.

Thorburn AW, Baldwin ME, Rosella G, Zajac JD, Fabris S, Song S, Proietto J.

Diabetologia. 1999 Apr;42(4):419-26.

PMID:
10230645
34.

NOTES: a system for defending patient education through effective documentation.

Baldwin ME, Stephenson LC.

Home Healthc Nurse. 1998 Apr;16(4):253-5. No abstract available.

PMID:
9592427
35.

Mapping of the gene for vascular endothelial growth factor-D in mouse and man to the X chromosome.

Jenkins NA, Woollatt E, Crawford J, Gilbert DJ, Baldwin ME, Sutherland GR, Copeland NG, Achen MG.

Chromosome Res. 1997 Nov;5(7):502-5. No abstract available.

PMID:
9421270

Supplemental Content

Loading ...
Support Center